Long-Term Follow-up Study for Patients Previously Treated With JCAR015

  • Observational
  • Not Recruiting
  • NCT02813252
Eligibility Details Visit Clinicaltrials.gov

Long-Term Follow-up Protocol for Subjects Treated With JCAR015

This study will provide long-term follow-up for patients who have received treatment with JCAR015 in a previous clinical trial. In this study, patients will be followed for up to 15 years after their last dose of JCAR015 for evaluation of delayed adverse events, presence of persisting JCAR015 vector sequences, and survival.


Age Group
18 Years and up

Accepting Healthy Volunteers?

Inclusion criteria:

         - Patients who have received at least one dose of JCAR015 in a previous treatment protocol.

         - Patients who have provided informed consent for the long-term follow-up study prior to study participation.

        Exclusion criteria:

         - None. All patients who have previously received JCAR015 treatment are eligible for this long-term follow-up study.

At a Glance

National Government IDNCT02813252


Lead SponsorJuno Therapeutics, Inc.

Lead PhysicianMichael R. Bishop


18 Years and up
Not Recruiting